4.5 Article

Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008

Journal

BMC INFECTIOUS DISEASES
Volume 12, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1471-2334-12-260

Keywords

Bacteraemia; Epidemiology; Incidence; Mortality; Comorbidity; Alcoholism; Staphylococcus aureus; Charlson comorbidity index

Ask authors/readers for more resources

Background: The objective of this study was to assess temporal changes in incidence and short term mortality of Staphylococcus aureus bacteraemia (SAB) from 1995 through 2008. Methods: The study was conducted as a nation-wide observational cohort study with matched population controls. The setting was hospitalized patients in Denmark 1995-2008. Uni- and multivariate analyses were used to analyze the hazard of death within 30 days from SAB. Results: A total of 16 330 cases of SAB were identified: 57% were hospital-associated (HA), 31% were community-acquired (CA) and 13% were of undetermined acquisition. The overall adjusted incidence rate remained stable at 23 per 100 000 population but the proportion of SAB cases older than 75 years increased significantly. Comorbidity in the cohort as measured by Charlson comorbidity index (CCI) score and alcohol-related diagnoses increased over the study period. In contrast, among the population controls the CCI remained stable and alcohol-related diagnoses increased slightly. For HA SAB crude 30-day mortality decreased from 27.8% to 21.8% (22% reduction) whereas the change for CA SAB was small (26.5% to 25.8%). By multivariate Cox regression, age, female sex, time period, CCI score and alcohol-related diagnoses were associated with increased mortality regardless of mode of acquisition. Conclusions: Throughout a 14-year period the overall incidence of SAB remained stable while the overall short term prognosis continued to improve despite increased age and accumulation of comorbidity in the cohort. However, age and comorbidity were strong prognostic indicators for short term mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19

Maximilian Peter Gotz, Mikkel-Ole Skjoedt, Rafael Bayarri-Olmos, Cecilie Bo Hansen, Laura Perez-Alos, Ida Jarlhelt, Thomas Benfield, Anne Rosbjerg, Peter Garred

Summary: The study revealed a significant association between MASP-2 and complement activation and inflammatory markers in COVID-19 patients, indicating a potential role of MASP-2 in COVID-19 pathophysiology.

JOURNAL OF INNATE IMMUNITY (2023)

Article Infectious Diseases

Short-course antibiotic therapy for hospitalized patients with early clinical response in community-acquired pneumonia: a multicentre cohort study

Simone Bastrup Israelsen, Markus Fally, Britta Tarp, Lilian Kolte, Pernille Ravn, Thomas Benfield

Summary: This study aimed to investigate the efficacy and safety of short-course antibiotic therapy in routine clinical settings among patients hospitalized with community-acquired pneumonia (CAP) and early clinical response. The study found similar outcomes in terms of mortality, readmission, and new antibiotic prescriptions between short-course and prolonged-course therapies, supporting the use of short-course therapy in routine clinical settings.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Pharmacology & Pharmacy

Experience with sotrovimab treatment of SARS-CoV-2-infected patients in Denmark

Line Dahlerup Rasmussen, Anne-Mette Lebech, Anne Ovrehus, Birgitte Klindt Poulsen, Hanne Rolighed Christensen, Henrik Nielsen, Isik Somuncu Johansen, Lars Haukali Omland, Lothar Wiese, Marie Helleberg, Merete Storgaard, Michael Dalager-Pedersen, Thomas A. Rasmussen, Thomas Benfield, Tonny Studsgaard Petersen, Ase Bengard Andersen, Mie Agermose Gram, Marc Stegger, Sofie Marie Edslev, Niels Obel

Summary: This study aims to evaluate the experience with the use of sotrovimab in high-risk groups following SARS-CoV-2 infection. The study found that over 90% of the patients treated with sotrovimab belonged to high-risk groups. Sotrovimab-treated individuals remained at a high risk of hospitalization and death, which was strongly associated with immunocompromised state and age. Receiving more than 3 COVID-19 vaccines was associated with a decreased risk of death and hospitalization.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Infectious Diseases

Community-acquired Staphylococcus aureus meningitis in adults

Thijs M. van Soest, Maria Birgitte Sondermolle, Matthijs C. Brouwer, Nora Chekrouni, Anders Rhod Larsen, Andreas Petersen, Nina M. van Sorge, Henrik Nielsen, Diederik van de Beek, Jacob Bodilsen, D. A. S. G. I. B. study group DASGIB study group

Summary: This study assessed the clinical characteristics and outcomes of patients with community-acquired Staphylococcus aureus meningitis from Denmark and the Netherlands. The results showed that community-acquired S. aureus meningitis mainly occurred in patients with concurrent endocarditis or spondylodiscitis, and had a high case fatality rate.

JOURNAL OF INFECTION (2023)

Article Multidisciplinary Sciences

Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study

Zitta Barrella Harboe, Casper Roed, Jon G. Holler, Fahim Iqbal Khan, Aya Nihad Abdulrahman Abdulrahman, Stefan Lundby Mulverstedt, Betina Lindgaard-Jensen, Barbara Bonnesen Bertelsen, Christian Soborg, Thyge Lynghoj Nielsen, Line Vinum Hansen, Birgitte Lindegaard Madsen, Andrea Browatzki, Mads Eiberg, Peter Haahr Bernhard, Emilie Marie Juelstorp Pedersen, Gertrud Baunbaek Egelund, Arnold Matovu Dungu, Adin Sejdic, Inger Hee Mabuza Mathiesen, Naja Z. Jespersen, Pelle Trier Petersen, Lars Nielsen, Micha Phill Gronholm Jepsen, Thomas Ingemann Pedersen, Robert Eriksson, Hans Eric Sebastian Seitz-Rasmussen, Morten Bestle, Henrik Andersen, Ulrik Skram, Mads Romer Skott, Sarah Altaraihi, Pradeesh Sivapalan, Jens-Ulrik Staehr Jensen, Kristian Bagge, Kristina Melbardis Jorgensen, Maja Johanne Sondergaard Knudsen, Thomas Leineweber, Uffe Vest Schneider, Magnus Glindvad Ahlstrom, Sofie Rytter, Nina le Dous, Pernille Ravn, Nanna Reiter, Daria Podlekareva, Andreas Knudsen, Stine Johnsen, Lars-Erik Kristensen, Caecilie Leding, Bastian Bryan Hertz, Thomas Benfield, Ole Kirk, Jon Gitz Holler, Sisse Rye Ostrowski, Sigurdur Thor Sigurdsson, Anders Perner, Nikolai Kirkby, Martin Schou Pedersen, Maarten van Wijhe, Lone Simonsen, Peter Michael Bager, Tyra Grove Krause, Marianne Voldstedlund, Lasse Engbo Christiansen, Marc Stegger, Arieh Cohen, Jannik Fonager, Anders Fomsgaard, Rebecca Legarth, Morten Rasmussen, Sophie Gubbels, Jan Wohlfahrt, Troels Lillebaek, Caroline Klint Johannesen, Maarten van Wijhe, Thea K. Fischer

Summary: This study compared the intrinsic virulence of the SARS-CoV-2 omicron variant and the delta variant in hospitalized adults with COVID-19. The results showed that patients with the omicron variant had milder hypoxemia and higher 30- and 60-day survival rates compared to those with the delta variant, mainly due to a higher proportion of omicron patients vaccinated with three doses of an mRNA vaccine.

PLOS ONE (2023)

Article Immunology

Coronary Artery Disease in Persons With Human Immunodeficiency Virus Without Detectable Viral Replication

Andreas D. Knudsen, Andreas Fuchs, Thomas Benfield, Jan Gerstoft, Lars Kober, Marius Troseid, Klaus F. Kofoed, Susanne D. Nielsen

Summary: Almost half of virologically suppressed persons with human immunodeficiency virus had atherosclerosis, and 18% had obstructive coronary artery disease. Interleukin 6 was associated with coronary artery disease but adjusting for cardiovascular risk factors attenuated the association.

OPEN FORUM INFECTIOUS DISEASES (2023)

Editorial Material Ethics

Time to treat the climate and nature crisis as one indivisible global health emergency

Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Gregory E. Erhabor, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski

AMERICAN JOURNAL OF BIOETHICS (2023)

Article Immunology

Metabolic syndrome, soluble CD40L, and biomarkers of endothelial dysfunction in people living with HIV

Mads-Holger B. Jacobsen, Andreas D. Knudsen, Thomas Benfield, Sisse R. Ostrowski, Shoaib Afzal, Edith W. Sorensen, Susanne D. Nielsen, Marco Gelpi

Summary: This study investigated the association between soluble CD40 ligand, soluble thrombomodulin, and syndecan-1 with metabolic syndrome in people with HIV, and their association with HIV-specific variables. The results indicated that high levels of soluble CD40 ligand were associated with an increased risk of metabolic syndrome.

APMIS (2023)

Article Biochemistry & Molecular Biology

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

Jesper D. Gunst, Jesper F. Hojen, Marie H. Pahus, Miriam Rosas-Umbert, Birgitte Stiksrud, James H. Mcmahon, Paul W. Denton, Henrik Nielsen, Isik S. Johansen, Thomas Benfield, Steffen Leth, Jan Gerstoft, Lars Ostergaard, Mariane H. Schleimann, Rikke Olesen, Henrik Stovring, Line Vibholm, Nina Weis, Anne M. Dyrhol-Riise, Karen B. H. Pedersen, Jillian S. Y. Lau, Dennis C. Copertino, Noemi Linden, Tan T. Huynh, Victor Ramos, R. Brad Jones, Sharon R. Lewin, Martin Tolstrup, Thomas A. Rasmussen, Michel C. Nussenzweig, Marina Caskey, Dag Henrik Reikvam, Ole S. Sogaard

Summary: In people with HIV-1 undergoing antiretroviral treatment interruption, combining lefitolimod with broadly neutralizing antibodies (bNAbs) did not delay viral rebound beyond that achieved with bNAbs alone, raising the question of how to optimize combination immunotherapy to control HIV-1.

NATURE MEDICINE (2023)

Article Immunology

Risk of New-onset Type 1 Diabetes in Danish Children and Adolescents After SARS-CoV-2 Infection: A Nationwide, Matched Cohort Study

Louise Bering, Anne Vinggaard Christensen, Nina Marie Birk, Lau Caspar Thygesen, Henning Bundgaard, Thomas Benfield, Ulrikka Nygaard, Jesper Johannesen, Susanne Dam Nielsen, Selina Kikkenborg Berg

Summary: This nationwide matched cohort study investigated the association between SARS-CoV-2 infection and new-onset type 1 diabetes (T1D) in children and adolescents. The study found that the risk of new-onset T1D in children and adolescents was not significantly increased after SARS-CoV-2 infection within 6 months.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Article Medicine, General & Internal

HIV-associated lung disease

Ioannis Konstantinidis, Kristina Crothers, Ken M. Kunisaki, M. Bradley Drummond, Thomas Benfield, Heather J. Zar, Laurence Huang, Alison Morris

Summary: HIV-associated lung disease includes both acute, infectious illnesses such as tuberculosis and chronic, non-infectious conditions such as chronic obstructive lung disease and lung cancer. This Primer provides an overview of the epidemiology, mechanisms, diagnosis and treatment of these lung conditions, as well as their impact on patient quality of life and future research directions.

NATURE REVIEWS DISEASE PRIMERS (2023)

Article Immunology

Decreased Pneumococcal Carriage Among Older Adults in Denmark During the COVID-19 Lockdown

Michaela Tinggaard, Hans-Christian Slotved, Randi Fons Petersen, Nichlas Hovmand, Thomas Benfield

Summary: A study found that the carriage rate of Streptococcus pneumoniae among older adults in Denmark decreased during the COVID-19 lockdown and increased to pre-pandemic levels after the reopening of society.

OPEN FORUM INFECTIOUS DISEASES (2023)

Editorial Material Humanities, Multidisciplinary

Time to treat the climate and nature crisis as one indivisible global health emergency

Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Gregory E. Erhabor, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski

FASHION THEORY-THE JOURNAL OF DRESS BODY & CULTURE (2023)

Editorial Material Sociology

Time to treat the climate and nature crisis as one indivisible global health emergency

Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Gregory E. Erhabor, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski

FOOD CULTURE & SOCIETY (2023)

Editorial Material History

Time to treat the climate and nature crisis as one indivisible global health emergency

Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Gregory E. Erhabor, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski

EUROPEAN REVIEW OF HISTORY-REVUE EUROPEENNE D HISTOIRE (2023)

No Data Available